These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7950168)

  • 1. rHuEPO in the treatment of postpartum anemia: subcutaneous versus intravenous administration.
    Zimmermann R; Breymann C; Huch R; Huch A
    Clin Investig; 1994; 72(6 Suppl):S25-30. PubMed ID: 7950168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Law CB; Ting SM; Li P; Lai KN
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and intravenous iron therapy in postpartum anaemia.
    Wågström E; Akesson A; Van Rooijen M; Larson B; Bremme K
    Acta Obstet Gynecol Scand; 2007; 86(8):957-62. PubMed ID: 17653881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous versus subcutaneous administration of recombinant human erythropoietin in patients on haemodialysis and CAPD.
    Eidemak I; Friedberg MO; Ladefoged SD; Løkkegaard H; Pedersen E; Skielboe M
    Nephrol Dial Transplant; 1992; 7(6):526-9. PubMed ID: 1320232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anemia in puerperium; parenteral iron substitution renders erythropoietin therapy dispensable].
    Lebrecht A; Häberlin F; Eberhard J
    Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):167-70. PubMed ID: 7665066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemoglobin response to subcutaneous versus intravenous epoetin alfa administration in iron-replete haemodialysis patients.
    Leikis MJ; Kent AB; Becker GJ; McMahon LP
    Nephrology (Carlton); 2004 Jun; 9(3):153-60. PubMed ID: 15189176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.
    Auerbach M; Ballard H; Trout JR; McIlwain M; Ackerman A; Bahrain H; Balan S; Barker L; Rana J
    J Clin Oncol; 2004 Apr; 22(7):1301-7. PubMed ID: 15051778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
    Krafft A; Breymann C
    J Obstet Gynaecol Res; 2011 Feb; 37(2):119-24. PubMed ID: 21159035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
    Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF
    Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous versus oral iron therapy for postpartum anaemia.
    Bhandal N; Russell R
    BJOG; 2006 Nov; 113(11):1248-52. PubMed ID: 17004982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
    Massa E; Madeddu C; Lusso MR; Gramignano G; Mantovani G
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):175-82. PubMed ID: 16213740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
    J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
    Baron F; Frère P; Fillet G; Beguin Y
    Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin in the treatment of postpartum anemia.
    Huch A; Eichhorn KH; Danko J; Lauener PA; Huch R
    Obstet Gynecol; 1992 Jul; 80(1):127-31. PubMed ID: 1603482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.